Other
Vendor and manufacturer receivables
CVS Health Vendor and manufacturer receivables decreased by 9.1% to $14.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $14.21B to $14.14B. Over 4 years (FY 2021 to FY 2025), Vendor and manufacturer receivables shows an upward trend with a 10.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026May 6, 2026
Metric ID:
other_vendor_and_manufacturer_receivablesHistorical Data
16 periods
| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.57B | $13.53B | $12.4B | $13.36B | $14.91B | $16.65B | $15.71B | $12.68B | $13.53B | $15.62B | $13.89B | $14.21B | $15.25B | $17.78B | $15.56B | $14.14B |
| QoQ Change | — | +28.0% | -8.4% | +7.8% | +11.6% | +11.6% | -5.6% | -19.3% | +6.7% | +15.5% | -11.1% | +2.3% | +7.3% | +16.6% | -12.5% | -9.1% |
| YoY Change | — | — | +17.2% | — | — | +23.0% | +26.8% | -5.1% | -9.3% | -6.2% | -11.6% | +12.0% | +12.7% | +13.8% | +12.0% | -0.4% |
Range$10.57B – $17.78B
CAGR+8.1%
Avg YoY Growth+7.1%
Median YoY Growth+12.0%
Current Streak2 quarters decline
Frequently Asked Questions
- What is CVS Health's vendor and manufacturer receivables?
- CVS Health (CVS) reported vendor and manufacturer receivables of $14.14B in Q1 2026.
- How has CVS Health's vendor and manufacturer receivables changed year-over-year?
- CVS Health's vendor and manufacturer receivables decreased by 0.4% year-over-year, from $14.21B to $14.14B.
- What is the long-term trend for CVS Health's vendor and manufacturer receivables?
- Over 4 years (2021 to 2025), CVS Health's vendor and manufacturer receivables has grown at a 10.1% compound annual growth rate (CAGR), from $10.57B to $15.56B.